ASND insider trading

Open-market stock trades by Ascendis Pharma (ASND) executives and directors: who bought or sold, how many shares, at what price and when.

ASND insider trades

DateInsiderRoleTradeSharesPriceValue
Sep 8, 2026Bodenhoff MadsSVP & PAOSell3,000$270.19$810.57K
Sep 2, 2026HOLTUG LARSdirectorSell236$264.13$62.33K
Aug 14, 2026BIENAIME JEAN JACQUESdirectorBuy900$246.91$222.22K
Aug 14, 2026BIENAIME JEAN JACQUESdirectorBuy1,100$245.85$270.44K
Jun 2, 2026SMITH SCOTT THOMASEVP & Chief Financial OfficerBuy100$219.00$21.90K
May 29, 2026BIENAIME JEAN JACQUESdirectorBuy100$223.50$22.35K
May 29, 2026BIENAIME JEAN JACQUESdirectorBuy200$222.30$44.46K
May 29, 2026BIENAIME JEAN JACQUESdirectorBuy200$223.76$44.75K
May 29, 2026SMITH SCOTT THOMASEVP & Chief Financial OfficerBuy250$223.32$55.83K
May 26, 2026BIENAIME JEAN JACQUESdirectorBuy200$239.37$47.87K
May 26, 2026BIENAIME JEAN JACQUESdirectorBuy200$236.24$47.25K
May 11, 2026JENSEN FLEMMING STEENSee RemarksSell19,460$238.49$4.64M

Updated 2026-11-03 00:01 UTC